This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/517755-eu-noevidence-astrazeneca-vaccine-death/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| 'No indication' AstraZeneca Covid vaccine causes death, EU drug regulator says after Austria pauses rollout over safety fears | 'No indication' AstraZeneca Covid vaccine causes death, EU drug regulator says after Austria pauses rollout over safety fears |
| (6 months later) | |
| There is no evidence so far to link the death and illness of two people in Austria to their vaccination with AstraZeneca's Covid-19 jab, the European Medicines Agency (EMA) has said after a preliminary review of the batch used. | There is no evidence so far to link the death and illness of two people in Austria to their vaccination with AstraZeneca's Covid-19 jab, the European Medicines Agency (EMA) has said after a preliminary review of the batch used. |
| Austria's public health agency announced on Sunday that it was suspending its rollout of a batch of the jabs after a 49-year-old woman died from multiple thrombosis 10 days after being given the AstraZeneca vaccine. | Austria's public health agency announced on Sunday that it was suspending its rollout of a batch of the jabs after a 49-year-old woman died from multiple thrombosis 10 days after being given the AstraZeneca vaccine. |
| Another woman, aged 35, who received the vaccine was hospitalized with pulmonary embolism, while a further two cases of blood clotting in patients given jabs from the same batch have been reported since Tuesday, the EMA said. | Another woman, aged 35, who received the vaccine was hospitalized with pulmonary embolism, while a further two cases of blood clotting in patients given jabs from the same batch have been reported since Tuesday, the EMA said. |
| "There is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine," the regulator said in a statement on Wednesday. | "There is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine," the regulator said in a statement on Wednesday. |
| The Austrian authorities this week launched an investigation into 'Batch ABV5300' of 1 million doses of the AstraZeneca vaccine, some of which were also sent to 16 other EU countries. | The Austrian authorities this week launched an investigation into 'Batch ABV5300' of 1 million doses of the AstraZeneca vaccine, some of which were also sent to 16 other EU countries. |
| The EMA said a "quality defect is considered unlikely at this stage," but said that its own Pharmacovigilance Risk Assessment Committee would also review reported instances of blood-clotting post-vaccination. | The EMA said a "quality defect is considered unlikely at this stage," but said that its own Pharmacovigilance Risk Assessment Committee would also review reported instances of blood-clotting post-vaccination. |
| Blood-clotting or "thromboembolic events" in people given the vaccine developed by AstraZeneca with Oxford University are no more common than in the general population, the EMA noted. | Blood-clotting or "thromboembolic events" in people given the vaccine developed by AstraZeneca with Oxford University are no more common than in the general population, the EMA noted. |
| Of the 3 million EU citizens to receive the vaccine since the EMA approved it in January, 22 cases of thromboembolic events have been reported, as of March 9, according to the EU regulator. | Of the 3 million EU citizens to receive the vaccine since the EMA approved it in January, 22 cases of thromboembolic events have been reported, as of March 9, according to the EU regulator. |
| Like this story? Share it with a friend! | Like this story? Share it with a friend! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |